| Dipeptidyl peptidase‐4 inhibitors moderate the risk of genitourinary tract infections associated with sodium‐glucose co‐transporter‐2 inhibitors GP Fadini, BM Bonora, S Mayur, M Rigato, A Avogaro Diabetes, Obesity and Metabolism 20 (3), 740-744, 2018 | 39 | 2018 |
| Data mining differential clinical outcomes associated with drug regimens using adverse event reporting data M Sarangdhar, S Tabar, C Schmidt, A Kushwaha, K Shah, JE Dahlquist, ... Nature biotechnology 34 (7), 697-700, 2016 | 37 | 2016 |
| Glucagon-like peptide-1 receptor agonists are not associated with retinal adverse events in the FDA Adverse Event Reporting System GP Fadini, M Sarangdhar, A Avogaro BMJ Open Diabetes Research and Care 6 (1), e000475, 2018 | 24 | 2018 |
| Pharmacovigilance assessment of the association between Fournier’s gangrene and other severe genital adverse events with SGLT-2 inhibitors GP Fadini, M Sarangdhar, F De Ponti, A Avogaro, E Raschi BMJ Open Diabetes Research and Care 7 (1), e000725, 2019 | 23 | 2019 |
| Pharmacovigilance evaluation of the association between DPP-4 inhibitors and heart failure: stimulated reporting and moderation by drug interactions GP Fadini, M Sarangdhar, A Avogaro Diabetes Therapy 9 (2), 851-861, 2018 | 15 | 2018 |
| Spiking Neurons: Is coincidence-factor enough for comparing responses with fluctuating membrane voltage? M Sarangdhar, C Kambhampati Proceedings of the World Congress on Engineering 2, 2-4, 2008 | 10 | 2008 |
| Spiking Neurons and Synaptic Stimuli: Neural Response Comparison Using Coincidence-Factor M Sarangdhar, C Kambhampati Advances in Electrical Engineering and Computational Science, 681-692, 2009 | 6 | 2009 |
| Spiking Neurons and Synaptic Stimuli: Determining the Fidelity of Coincidence-Factor in Neural Response Comparison. M Sarangdhar, C Kambhampati Engineering Letters 16 (4), 2008 | 6 | 2008 |
| System and method for data mining very large drugs and clinical effects databases B Aronow, M Sarangdhar, SC Tabar, AG Jegga US Patent 10,769,242, 2020 | 5 | 2020 |
| A numerical model for Hodgkin-Huxley neural stimulus reconstruction M Sarangdhar, C Kambhampati IAENG International Journal of Computer Science 38 (1), 89-94, 2011 | 5 | 2011 |
| Rheumatic and musculoskeletal adverse events with immune checkpoint inhibitors: data from the United States Food and Drug Administration adverse event reporting system XN Pundole, M Sarangdhar, ME Suarez-Almazor Journal of Immunotherapy and Precision Oncology 2 (3), 65-73, 2019 | 4 | 2019 |
| Using systems biology-based analysis approaches to identify mechanistically significant adverse drug reactions: Pulmonary complications from combined use of anti-TNFα agents … M Sarangdhar, A Kushwaha, J Dahlquist, A Jegga, B Aronow AMIA Summits on Translational Science Proceedings 2013, 151, 2013 | 4 | 2013 |
| The impact of marijuana on antidepressant treatment in adolescents: Clinical and pharmacologic considerations SE Vaughn, JR Strawn, EA Poweleit, M Sarangdhar, LB Ramsey Journal of personalized medicine 11 (7), 615, 2021 | 3 | 2021 |
| Network analyses of biomedical and genomic big data M Sarangdhar, RC Gudivada, RB Shrestha, Y Wang, AG Jegga Big Data of Complex Networks, 13-36, 2016 | 2 | 2016 |
| Pharmacogenomic prediction of treatment-induced severe lung toxicity in Hodgkin lymphoma (HL). R Karns, M Sarangdhar, B Aronow, M Basu, CL Schwartz, KM Kelly, ... Journal of Clinical Oncology 34 (15_suppl), 7522-7522, 2016 | 2 | 2016 |
| Predicting Drug Response and Novel Therapeutic Candidates Using Signatures of Molecular Alterations in Hematologic Malignancies G Labilloy, E O'Brien, B VanCauwenbergh, L Byerly, M Basu, W Seibel, ... Blood 132, 2219, 2018 | 1 | 2018 |
| OP0197 Rheumatic and musculoskeletal adverse events associated with immune checkpoint inhibitors: data mining of the us food and drug administration adverse event reporting system X Pundole, M Sarangdhar, ME Suarez-Almazor Annals of the Rheumatic Diseases 77 (Suppl 2), 147-148, 2018 | 1 | 2018 |
| High-density data mining to identify unique toxicities of adolescent/young adult cancer treatment: a Report from the Children's Oncology Group M Sarangdhar, SL Whiteway, JL Heath, EA Raetz, E Hibbits, M Devidas, ... Blood 130, 2562, 2017 | 1 | 2017 |
| Next generation sequencing (NGS) to identify targetable recurring mutations and exceptional responders in relapsed and high-risk childhood and adolescent/young adult (AYA … B Turpin, R Karns, M Sarangdhar, BD Weiss, JI Geller, M Absalon, ... Journal of Clinical Oncology 33 (15_suppl), 11011-11011, 2015 | 1 | 2015 |
| Mo1223 Lower Expression of PPARγ in AVM Tissue Provides a Novel Therapeutic Target for Use of Glitazones in Treatment of GI Bleeding: Validation of Our Large-Scale Clinical … M Sarangdhar, AR Gruenzel, MB Yacyshyn, BJ Aronow, B Yacyshyn Gastroenterology 148 (4), S-642, 2015 | 1 | 2015 |
Bruce AronowCincinnati Children's Hospital Medical Center; University of CincinnatiVerified email at cchmc.org
